The mission of Montefiore Health System/ Albert Einstein College of Medicine is to heal, to teach, to discover and to advance the health of the communities we serve. From its beginning in 1884, as a facility for the care of patients with tuberculosis and other chronic illnesses, to the new millennium, Montefiore has been at the forefront of patient care, research and education and steadfast commitment to its community. At the intersection of Einstein science and Montefiore medicine is our commitment to scientific inquiry. This commitment has resulted in the creation of the Montefiore-Einstein Centers of Excellence in cancer care, cardiovascular services, transplantation and children’s health, where nationally recognized investigators and multidisciplinary clinical teams collaborate to develop and deliver advanced, innovative care. Montefiore's partnership with Einstein advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Together, the two institutions are among 38 academic medical centers nationwide to be awarded a prestigious Clinical and Translational Science Award (CTSA) by the National Institutes of Health. Dr. Ozuah is the President and CEO of Montefiore Medicine, the umbrella organization for Montefiore Health System and Albert Einstein College of Medicine. Montefiore Health System (MHS) is one of the nation's largest, consisting of ten hospitals; a primary and specialty care network of more than 200 locations across Westchester County, the lower Hudson Valley and the Bronx; an extended care facility; the Montefiore School of Nursing, and our Albert Einstein College of Medicine.
The Division of Cognitive and Motor Aging (DCMA) seeks to investigate the links between cognitive & motor pathways in an aging population, and is comprised of multiple projects including the Central Control of Mobility and Aging (CCMA) study (R01AG036921-01A1, PI: Holtzer; R01AG044007-01, PI: Verghese), a clinical trial to investigate the effect of cognitive remediation on walking (R01AG050448, PI: Verghese & Holtzer) as well as CFAR Supplement/HIV aging: Novel markers and interventions for cognitive dysfunction (5P30AI051519-09s; PI: Verghese). The DCMA is directed by Joe Verghese, MBBS, a Professor of Neurology at AECOM and an expert in the field of mobility. Roee Holtzer, Ph.D., Associate Professor at the Ferkauf Graduate School of Psychology and the department of Neurology is also affiliated with the DCMA and has specific interests in attention and executive control processes in aging. The DCMA is strongly committed to fostering aging research within AECOM, developing research careers, and providing a unique opportunity to examine the intersection of cognitive and motor function vis-à-vis aging, dementia, and disease affecting the central nervous system.
The PICS intern will help facilitate evaluation and dissemination of clinical research within the health system. This summer internship will also meet the mission of teaching. The intern will learn about normal and pathological aging as well as research methods to address these topics.
The PICS intern will be working closely with Dr. Mirnova Ceïde to support her ongoing research projects. Dr. Ceïde’s research on the prevention and management of cognitive impairment and associated behavioral symptoms. On-going research projects for which the PICS intern may be asked to support include the following:
The Motoric-cognitive, Structural, and Inflammatory Correlates of Apathy in Older Adults: This research supported by an NIH National Institutes of Aging Supplement to Promote Diversity. The overall goal of this supplement is to prepare the candidate for a career as an independent researcher capable of identifying populations of older adults at risk for dementia, particularly those with apathy, and evaluating the neural and biological pathology of these behavioral symptoms. Our central hypothesis is that apathy is a behavioral marker of neural and inflammatory abnormalities, which occur early in dementia pathogenesis. Our MCR consortium will leverage 8 established cohorts to study the pathogenesis of Alzheimer’s disease and related dementias via the Motoric Cognitive Risk Disorder (MCR) pathway in ~11,000 community-dwelling older adults. This proposed supplement expands on the aims of the parent grant, which are to: 1) identify biological mechanisms underlying MCR incidence, 2) establish neuroanatomical substrates of MCR, and 3) compare and contrast biology of MCR and Mild Cognitive Impairment.
Montefiore Hudson Valley Center of Excellence for Alzheimer’s Disease (CEAD: This research focuses on data gathering and management of patients who present to the center. Also we are conducting small pilot projects with community projects to minimize depression in persons with cognitive impairment and increase support for caregiver. As we implement varied programs, we are refining the clinical measures that we use to screen patients and their families.
|# of weeks||Required Dates||Start Time||End Time||Public Transit||Housing||Format|
Students can explore a short term rental or arrangements to stay with family.
Alternatively the internship can be conducted remotely.
The ideal candidate will:
- Have interest in aging and dementia related research
- Have a solid background in psychology and health sciences
- Be proficient in Microsoft Office, namely MS Excel and Word, and have the ability to apply technology to resolve problems
- Have basic knowledge of SPSS, SAS, or other statistical software and some prior experience with statistical data analysis
- Have strong communication skills and enjoy writing
- Demonstrate independent initiative and an ability to manage competing project priorities
- Work well in a team setting.
- Background Check
- Drug Screening
- CITI training